Literature DB >> 2186770

Hypercalcaemia--new mechanisms for old observations.

J Waxman1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2186770      PMCID： PMC1971611          DOI： 10.1038/bjc.1990.145

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures.

Authors:  J A Lorenzo; J Quinton; S Sousa; L G Raisz
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

3.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

Review 4.  Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism.

Authors:  J F Habener; M Rosenblatt; J T Potts
Journal:  Physiol Rev       Date:  1984-07       Impact factor: 37.312

Review 5.  The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza; E L Simpson; J W Jacobs; T J Martin
Journal:  N Engl J Med       Date:  1984-06-28       Impact factor: 91.245

6.  Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.

Authors:  A H Tashjian; E F Voelkel; M Lazzaro; D Goad; T Bosma; L Levine
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

7.  Prostaglandins as mediators of bone resorption in renal and breast tumours.

Authors:  M Greaves; K J Ibbotson; D Atkins; T J Martin
Journal:  Clin Sci (Lond)       Date:  1980-03       Impact factor: 6.124

8.  Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.

Authors:  W J Burtis; T Wu; C Bunch; J J Wysolmerski; K L Insogna; E C Weir; A E Broadus; A F Stewart
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

9.  Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.

Authors:  E L Simpson; G R Mundy; S M D'Souza; K J Ibbotson; R Bockman; J W Jacobs
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

10.  Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1.

Authors:  R Felix; H Fleisch; P R Elford
Journal:  Calcif Tissue Int       Date:  1989-05       Impact factor: 4.333
View more
  1 in total

1.  The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy.

Authors:  M Bower; R C Stein; A Hedley; J Davenport; K Colston; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.